- Grants since 2016
- 113
- Awarded, last 5 years (where amounts are published)
- AUD 36M
- Funded works, last 5 years
- 761
- Funded works, all time
- 2 658
Grants
2020–2024 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Increasing resilience and reducing smoking for lower socio-economic groups
2020–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Remove the Mask: Reducing Anxiety and Distress for Head and Neck Cancer Radiotherapy Patients
2020–2021 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Targeting tissue-resident memory T cells in cancer immunotherapy
2020–2027 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Life and Health After Childhood Cancer: a national data linkage cohort study
2020–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Application of gene-silencing nanodrugs to inhibit medulloblastoma growth
2019–2020 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Investigation of the key immuno-genetic drivers of Primary Central Nervous System Lymphoma that occurs in patients with HIV infection
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Therapeutic targeting of a novel self-renewal signalling in leukaemia stem cells
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
The ECHO trial: Exercise during CHemotherapy for Ovarian cancer
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Targeting BCL-2 in estrogen receptor positive breast cancer
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Improving tumour targeting and delineation in lung cancer radiotherapy
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Mixed radiotherapy fractionation: modulating tumour microenvironment to stimulate and enhance immunotherapy
2019–2021 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Development of a translational bioengineered microenvironment model to advance pre-clinical acute myeloid leukaemia research
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation (NINJA)
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Targeting multidrug resistance protein 1 (MDR1) enhances the efficacy of Smac-mimetic-based therapy in Acute Myeloid Leukaemia.
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
P3BEP Trial: Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours: An Australian-Led, International Randomised Trial
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Personalising treatment and surveillance for colorectal cancer: prognostication with the circulating tumour-derived methylated DNA markers BCAT1 and IKZF1
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Targeting the NAD pathway as a new therapeutic strategy for high-risk leukaemia in children
2019–2021 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Targeting alternative SMAD-related suppressive signalling pathway enhance NK cell response
2019–2020 · research · Australian Brain Cancer Mission - Innovative Clinical Trials
The Innovative Clinical Trials Grant Opportunity's purpose is to increase brain cancer clinical trial activity in Australia by supporting new, high quality research. Novel and innovative clinical trial methodologies are encouraged.
2019–2020 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Targeting HCK in pancreatic ductal adenocarcinoma to restrict tumour growth and metastasis
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Targeting Polo-like kinase 1 as a novel therapeutic opportunity for Diffuse Intrinsic Pontine Gliomas
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Designing Chimeric Antigen Receptor T cells for Diffuse Intrinsic Pontine Glioma
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Mixed radiotherapy fractionation: modulating tumour microenvironment to stimulate and enhance immunotherapy
2019–2021 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Proteases and PAR2 are key mediators of cancer pain.
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Decoding the Dark Matter of the High-Risk Paediatric Cancer Genome
2019–2020 · research · Australian Brain Cancer Mission - Innovative Clinical Trials
The Innovative Clinical Trials Grant Opportunity's purpose is to increase brain cancer clinical trial activity in Australia by supporting new, high quality research. Novel and innovative clinical trial methodologies are encouraged.
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
SCORE: Shared care of Colorectal cancer survivors – A randomised controlled trial of hospital-based follow up versus shared hospital / general practice follow up for survivors of colorectal cancer (CRC)
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Personalised targeted therapy for adolescent and young adult medulloblastoma patients
2019–2021 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
N-cadherin inhibitors as vascular disrupting agents: increasing drug delivery to tumours and improving quality of life for cancer patients
2019–2022 · research · 2018 Priority-driven Collaborative Cancer Research Scheme
Exploiting CDK4/6 inhibition to treat medulloblastoma
2018–2023 · research · Medical Research Future Fund: Australian Brain Cancer Mission
Expand the capacity of the Australian and New Zealand Children's Haematology/Oncology Group
2018–2023 · research · Medical Research Future Fund: Australian Brain Cancer Mission
Zero Childhood Brain Cancer Program
2018–2023 · research · Medical Research Future Fund: Australian Brain Cancer Mission